Tunicamycin (0.5 ,ig/ml) significantly lowers (2 to 3 log,o) the infectious yield of herpes simplex virus type 1 grown in chicken embryo fibroblasts and in BSC1 cells. Although virus particles are formed and the synthesis of the viral deoxyribonucleic acid is only partially affected by the antibiotic, the glycosylation of herpesvirus glycopeptides is almost completely inhibited. The morphology of virus particles made in the presence of tunicamycin is similar to that of intact virus particles, as demonstrated by electron microscopy. This suggests that the absence of the carbohydrate side-chain from the viral glycopeptides does not affect the overall integrity of the virion but decreases very significantly the infectivity of these particles.Herpes simplex type 1 virus (HSV) is an enveloped deoxyribonucleic acid (DNA)-containing virus that assembles by budding from the cell nuclear membranes during its maturation process (13,14). The virion contains more than 30 structural polypeptides, to several of which carbohydrate side chains are covalently linked (7,21). The role of these glycopeptides in the overall integrity and stability of the virions is yet to be clarified.Tunicamycin is a glucosamine-containing antibiotic (23, 24) that specifically inhibits glycosylation of proteins (2,18,22). It blocks the transfer of N-acetylglucosamine-l-phosphate from uridine 5'-diphosphate-N-acetylglucosamine to the dolichyl monophosphate that serves as a lipid carrier (12,25) by inhibition of the transferase involved (6). Changes in the cell morphology and in the membrane properties of normal and virus-transformed fibroblasts occur in the presence of tunicamycin (3, 4). Tunicamycin significantly lowers the yield of several enveloped ribonucleic acid (RNA)-containing viruses (10,15,17,20). Whereas formation of virions of Semliki Forest, fowl plague (20), Sindbis, and vesicular stomatitis viruses (10) is greatly inhibited by tunicamycin, formation of Rous sarcoma and influenza virions occurs in the presence of the antibiotic; however, these virus particles show reduced infectivity and undetectable amounts of glycoproteins (15,20).In the present study, we examine the effect of tunicamycin on formation, structure, and infectivity of HSV particles to determine the involvement of the carbohydrate side chains of the glycopeptides in these viral processes and functions.
MATERIALS